StonvexLoading…
StonvexStonvexStonvexCore line items from YSG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $614.62M | $464.90M | $480.96M | $537.34M |
Operating Income | $-26.57M | $-113.01M | $-128.64M | $-134.68M |
Net Income | $-11.56M | $-97.02M | $-747.76M | $-118.22M |
EPS (Diluted) | $-0.01 | $-0.05 | $-0.05 | $-0.05 |
Total Assets | $550.11M | $544.01M | $705.08M | $850.01M |
Total Liabilities | $121.02M | $118.89M | $115.67M | $116.01M |
Cash & Equivalents | $109.45M | $111.98M | $117.87M | $219.36M |
Free Cash Flow OCF − CapEx | $-19.55M | $-40.61M | $-21.28M | $12.39M |
Shares Outstanding | 1.86B | 2.03B | 2.20B | 2.37B |